A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients.
Stephan
A
A
Rizk Hospital, Beirut, Lebanon.
Masri
M A
MA
Barbari
A
A
Aoun
S
S
Rizk
S
S
Kamel
G
G
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004304:Dosage Forms; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors
D000961:Antilymphocyte Serum; D004304:Dosage Forms; D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine